2019

1. Combination Therapy With Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients With Type 2 Diabetes: A Real-World Evidence Study

   Canadian Journal of Diabetes, Vol. 43, Núm. 3, pp. 186-192